CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 201522-08-2022
22-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201522-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Analyst/Investor Meet - Earnings Call - Q1 - Audio Recording08-08-2022
Results Earnings Call for Q1FY23 of Caplin Point Laboratories
Conference Call with Caplin Point Labs Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.06-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Board recommends Final Dividend
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 05, 2022, inter alia, has recommended a Final Dividend of Rs. 2 (100%) per equity share of Rs. 2 each for the financial year ended March 31, 2022. This shall be subject to approval of the shareholders at the forthcoming Annual General Meeting.05-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting05-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Reply To Clarification Sought By Exchange For Spurt In Volume In Shares Of The Company In Recent Past
This is in response to the BSE e - mail communication having Ref. L/SURV/ONL/PV/RS/ 2022- 2023 / 138 dated August 2, 2022. In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI (LODR) Regulations, 2015), the Company has promptly intimated to the Stock Exchanges of all events and information that may have a probable bearing on the operation / performance of the Company including all price sensitive information, as and when required from time to time. The Company do not have any undisclosed / potentially price sensitive information / event / announcement to be shared with the Stock Exchanges under Regulation 30 of SEBl (LODR) Regulations, 2015. Kindly take the same on record.02-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate that a conference call with the analysts/ fund houses post results will be held on Friday, August 5, 2022 at 17.00 hrs. (1ST) to discuss the financial performance of the Company for the quarter ended June 30, 2022.02-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Clarification sought from Caplin Point Laboratories Ltd
The Exchange has sought clarification from Caplin Point Laboratories Ltd on August 02, 2022, with reference to Movement in Volume.The reply is awaited.02-08-2022
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 201501-08-2022